FDA’s New Guidance on Medical Devices and Cybersecurity Vulnerabilities

Posted by Tim HudsonOn January 22, 2016, the FDA issued new draft guidance concerning how medical device makers should monitor, identify, and address cybersecurity vulnerabilities in their devices following their introduction into the marketplace.  The new guidance focuses on the reporting requirements of manufacturers relating to identified vulnerabilities and also recommends the implementation of comprehensive cybersecurity risk management programs. To learn more about the guidance, please click here to read Thompson & Knight’s recent client alert.